Corvus Pharmaceuticals Inc (CRVS)
1.73
+0.12
(+7.45%)
USD |
NASDAQ |
May 02, 16:00
1.72
-0.01
(-0.58%)
After-Hours: 20:00
Corvus Pharmaceuticals Cash from Investing (Quarterly): -2.318M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -2.318M |
| September 30, 2023 | 17.55M |
| June 30, 2023 | -4.289M |
| March 31, 2023 | 4.602M |
| December 31, 2022 | -3.882M |
| September 30, 2022 | 3.04M |
| June 30, 2022 | 3.14M |
| March 31, 2022 | -25.57M |
| December 31, 2021 | -1.999M |
| September 30, 2021 | 3.471M |
| June 30, 2021 | 15.24M |
| March 31, 2021 | 4.846M |
| December 31, 2020 | 0.463M |
| September 30, 2020 | 9.939M |
| June 30, 2020 | 6.67M |
| March 31, 2020 | 27.70M |
| December 31, 2019 | 4.595M |
| September 30, 2019 | -10.52M |
| Date | Value |
|---|---|
| June 30, 2019 | 0.416M |
| March 31, 2019 | 8.769M |
| December 31, 2018 | 6.534M |
| September 30, 2018 | 23.31M |
| June 30, 2018 | -63.66M |
| March 31, 2018 | 3.62M |
| December 31, 2017 | 10.67M |
| September 30, 2017 | 20.66M |
| June 30, 2017 | 35.32M |
| March 31, 2017 | 18.18M |
| December 31, 2016 | 8.878M |
| September 30, 2016 | 7.918M |
| June 30, 2016 | -0.605M |
| March 31, 2016 | -58.75M |
| December 31, 2015 | -70.83M |
| September 30, 2015 | 5.394M |
| June 30, 2015 | -26.28M |
| March 31, 2015 | -0.324M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-25.57M
Minimum
Mar 2022
27.70M
Maximum
Mar 2020
2.794M
Average
3.14M
Median
Jun 2022
Cash from Investing (Quarterly) Benchmarks
| Cyclacel Pharmaceuticals Inc | 0.00 |
| Arbutus Biopharma Corp | 22.22M |
| Oragenics Inc | -1.00M |
| Relmada Therapeutics Inc | 7.741M |
| MAIA Biotechnology Inc | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -5.167M |
| Free Cash Flow | -23.97M |
| Free Cash Flow Per Share (Quarterly) | -0.1053 |
| Free Cash Flow Yield | -28.85% |